查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609551

体外诊断市场规模、份额、趋势分析报告：按产品、按测试地点、按最终用途、按技术、按应用、按地区、细分市场预测，2025-2030

In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Test Location, By End-use, By Technology, By Application, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

体外诊断市场成长与趋势

Grand View Research, Inc.最新报告显示，预计到2030年，全球体外诊断市场规模将达1,187.2亿美元。

老年人口的增加、COVID-19 大流行以及诊断技术的进步正在推动这种技术的采用，预计在预测期内复合年增长率为 6.75%。可移植性、准确性和成本效益的技术进步预计将成为最有影响力的渲染驱动因素。 COVID-19 IVD 诊断的推出进一步加速了技术进步，加强了 PCR 等技术设备和耗材的采用。市场上的竞争对手越来越多地采用合约和伙伴关係策略来维持製造商和用户的持续业务流。

这些合约也是政府实验室严格价格控制策略的结果，压低了政府环境中的价格。例如，2021 年 4 月，Seegene, Inc. 的义大利子公司对公共采购进行了 1.0825 亿美元的竞标，用于供应 715 万份 SARS-CoV-2 诊断检测试剂和萃取试剂。 SARS-CoV-2诊断检测的主要目的是提供SARS-CoV-2诊断检测和SARS-CoV-2萃取试剂，增加了多方交易和供应链的复杂性。全球癌症和心血管疾病 (CVD) 的高盛行率预计将推动诊断创新，以促进早期诊断并满足消费者不断变化的需求。等离子 PCR 等新技术预计将在预测期内进入商业性市场，从而对现有产品的业务产生负面影响。

体外诊断市场报告亮点

  • 由于采用率和使用率不断上升，分子诊断预计将从 2025 年到 2030 年以复合年增长率增长最快。
  • 由于基因检测需求的快速增长以及临床需求未满足的低收入和中等收入国家技术先进的诊断检测的可用性不断增加，试剂占据了最大的市场占有率。
  • 由于全球进行了大量的传染病检查，感染疾病应用领域占据了最大的市场占有率。
  • 由于对新技术的高需求、大量关键参与企业、高盛行率和先进的医疗基础设施，北美将在 2024 年主导全球市场。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章体外诊断市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 体外诊断市场分析工具
    • 波特的分析
    • PESTEL分析
  • 消费行为分析
  • 价格分析
    • 装置
    • 试剂

第四章体外诊断市场：依产品分類的估算与趋势分析

  • 细分仪表板
  • 体外诊断市场：2024 年和 2030 年产品变化分析
  • 装置
  • 试剂
  • 服务

第五章 体外诊断市场：技术估算与趋势分析

  • 细分仪表板
  • 体外诊断市场：2024年及2030年技术波动分析
  • 免疫检测
    • 装置
    • 试剂
    • 服务
  • 血
    • 装置
    • 试剂
    • 服务
  • 临床化学
    • 装置
    • 试剂
    • 服务
  • 分子诊断
    • 装置
    • 试剂
    • 服务
  • 凝固
    • 装置
    • 试剂
    • 服务
  • 微生物
    • 装置
    • 试剂
    • 服务
  • 其他的
    • 装置
    • 试剂
    • 服务

第六章体外诊断市场：按应用、估计和趋势分析

  • 细分仪表板
  • 体外诊断市场：2024 年和 2030 年应用变化分析
  • 感染疾病
  • 糖尿病
  • 肿瘤学/癌症
  • 心臟病学
  • 肾臟病学
  • 自体免疫疾病
  • 药物测试
  • 其他的

第七章 体外诊断市场：依检测地点估算与趋势分析

  • 细分仪表板
  • 体外诊断市场：2024 年和 2030 年测试地点变化分析
  • 照护现场
  • 居家医疗
  • 其他的

第八章体外诊断市场：依最终用途分类的估计与趋势分析

  • 细分仪表板
  • 体外诊断市场：最终用途变化分析，2024 年和 2030 年
  • 医院
  • 实验室
  • 居家医疗
  • 其他的

第九章体外诊断市场：区域、估计和趋势分析

  • 2024 年及 2030 年体外诊断市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
    • 俄罗斯
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 科威特

第10章竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 2024年全球企业市场占有率分析
  • 企业热力图分析
  • 策略规划
    • 扩张
    • 併购
    • 伙伴关係与协作
    • 新产品发布
    • 研究与开发
  • 公司简介
    • QIAGEN
    • BD
    • bioMerieux SA
    • F. Hoffmann-La Roche, Ltd.
    • QuidelOrtho Corporation
    • Abbott
    • Agilent Technologies, Inc.
    • Siemens Healthineers AG
    • Bio-Rad Laboratories, Inc.
    • Danaher
    • Sysmex Corporation
    • Charles River Laboratories
    • Quest Diagnostics Incorporated
Product Code: 978-1-68038-080-4

In Vitro Diagnostic Market Growth & Trends:

The global in vitro diagnostics market size is expected to reach USD 118.72 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 6.75% over the forecast period driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users.

These agreements are also a result of the harsh price containment strategies for government laboratories, which lowers the price in government settings. For instance, in April 2021, the Italian subsidiary of Seegene, Inc. received a USD 108.25 million tenders for public procurement for the supply of extraction reagents, as well as 7.15 million SARS-CoV-2 diagnostic tests. However, it increases the multiparty nature and complexity of the supply chain. The high prevalence of cancer and Cardiovascular Diseases (CVDs) globally is anticipated to drive diagnostic innovation to facilitate early diagnosis and meet the constantly evolving needs of consumers. Novel technologies, such as plasmonic PCR, are anticipated to commercially enter the market during the forecast period, influencing the business of existing products adversely.

In Vitro Diagnostics Market Report Highlights:

  • Molecular diagnostics is anticipated to grow at the fastest CAGR from 2025 to 2030 owing to the rising adoption and usage rate
  • Reagents held the largest market share owing to the surge in demand for genetic testing and enhanced availability of technologically advanced diagnostic tests in lower and middle-income countries with unmet clinical needs
  • The infectious diseases application segment held the largest market share owing to the large volume of testing for infectious diseases globally
  • North America dominated the global market in 2024 owing to the high demand for novel technologies, a large pool of key players, high prevalence of diseases, and advanced healthcare infrastructure

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
    • 1.2.3. Application
    • 1.2.4. Test Location
    • 1.2.5. End Use
  • 1.3. Regional Scope
  • 1.4. Estimates and Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
  • 1.7. Details of primary research
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity flow analysis (Model 1)
      • 1.9.1.1. Approach 1: Commodity flow approach
    • 1.9.2. Volume price analysis (Model 2)
      • 1.9.2.1. Approach 2: Volume price analysis
  • 1.10. Research Scope and Assumptions
    • 1.10.1. List of Secondary Sources
    • 1.10.2. List of Primary Sources
    • 1.10.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. In Vitro Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Growing Geriatric Population
      • 3.2.1.2. Technological Advancements
      • 3.2.1.3. Increasing Demand For PoC Facilities
      • 3.2.1.4. Growing prevalence of target diseases
      • 3.2.1.5. Outbreak Of Covid-19
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Higher Cost Of Devices
      • 3.2.2.2. Stringent Regulatory Policies
  • 3.3. In Vitro Diagnostics Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Legal landscape
  • 3.4. Consumer Behavior Analysis
  • 3.5. Pricing Analysis
    • 3.5.1. Instruments
    • 3.5.2. Reagents

Chapter 4. In Vitro Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. In Vitro Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Million) (Volume Analysis)
  • 4.3. Instruments
    • 4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold)
  • 4.4. Reagents
    • 4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Tests Sold)
  • 4.5. Services
    • 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. In Vitro Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. In Vitro Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Million) (Volume Analysis)
  • 5.3. Immunoassay
    • 5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Instruments
      • 5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Reagents
      • 5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Services
      • 5.3.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Hematology
    • 5.4.1. Hematology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Instruments
      • 5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Reagents
      • 5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Services
      • 5.4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Clinical Chemistry
    • 5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Instruments
      • 5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Reagents
      • 5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. Services
      • 5.5.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Molecular Diagnostics
    • 5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Instruments
      • 5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. Reagents
      • 5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. Services
      • 5.6.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Coagulation
    • 5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.2. Instruments
      • 5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Reagents
      • 5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.4. Services
      • 5.7.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Microbiology
    • 5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.2. Instruments
      • 5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.3. Reagents
      • 5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.4. Services
      • 5.8.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.2. Instruments
      • 5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.3. Reagents
      • 5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.4. Services
      • 5.9.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. In Vitro Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. In Vitro Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Million)
  • 6.3. Infectious Disease
    • 6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Diabetes
    • 6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Oncology/Cancer
    • 6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Cardiology
    • 6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Nephrology
    • 6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Autoimmune Diseases
    • 6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Drug Testing
    • 6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10. Others
    • 6.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. In Vitro Diagnostics Market: Test Location Movement Analysis, 2024 & 2030 (USD Million)
  • 7.3. Point of Care
    • 7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Home-care
    • 7.4.1. Home-care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. In Vitro Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. In Vitro Diagnostics Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
  • 8.3. Hospitals
    • 8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Laboratory
    • 8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Home Care
    • 8.5.1. Home Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. In Vitro Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1. In Vitro Diagnostics Market Share, By Region, 2024 & 2030 (USD Million)
  • 9.2. North America
    • 9.2.1. North America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.2.3. Competitive Insights
      • 9.2.2.4. U.S. In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.3.3. Competitive Insights
      • 9.2.3.4. Canada In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.2.4. Mexico
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.4.3. Competitive Insights
      • 9.2.4.4. Mexico In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
  • 9.3. Europe
    • 9.3.1. Europe In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.2. UK
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.2.3. Competitive Insights
      • 9.3.2.4. UK In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.3.3. Competitive Insights
      • 9.3.3.4. Germany In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.4.3. Competitive Insights
      • 9.3.4.4. France In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.5.3. Competitive Insights
      • 9.3.5.4. Italy In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.6.3. Competitive Insights
      • 9.3.6.4. Spain In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.7. Sweden
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.7.3. Competitive Insights
      • 9.3.7.4. Sweden In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.8. Denmark
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.8.3. Competitive Insights
      • 9.3.8.4. Denmark In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.9.3. Competitive Insights
      • 9.3.9.4. Norway In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.10. Russia
      • 9.3.10.1. Key Country Dynamics
      • 9.3.10.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.10.3. Competitive Insights
      • 9.3.10.4. Russis In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.2. China
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. China In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.3. Japan
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. Japan In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. India In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.5. South Korea
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.5.3. Competitive Insights
      • 9.4.5.4. South Korea In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.6. Australia
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.6.3. Competitive Insights
      • 9.4.6.4. Australia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.7.3. Competitive Insights
      • 9.4.7.4. Thailand In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.8. Singapore
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.8.3. Competitive Insights
      • 9.4.8.4. Singapore In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
  • 9.5. Latin America
    • 9.5.1. Latin America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. Brazil In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.5.3. Argentina
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Argentina In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. Saudi Arabia
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. Saudi Arabia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.6.3. UAE
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. UAE In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.6.4. South Africa
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. South Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. Kuwait In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Global Company Market Share Analysis, 2024
  • 10.4. Company Heat Map Analysis
  • 10.5. Strategy Mapping
    • 10.5.1. Expansion
    • 10.5.2. Mergers & Acquisition
    • 10.5.3. Partnerships & Collaborations
    • 10.5.4. New Product Launches
    • 10.5.5. Research And Development
  • 10.6. Company Profiles
    • 10.6.1. QIAGEN
      • 10.6.1.1. Participant's Overview
      • 10.6.1.2. Financial Performance
      • 10.6.1.3. Product Benchmarking
      • 10.6.1.4. Recent Developments
    • 10.6.2. BD
      • 10.6.2.1. Participant's Overview
      • 10.6.2.2. Financial Performance
      • 10.6.2.3. Product Benchmarking
      • 10.6.2.4. Recent Developments
    • 10.6.3. bioMerieux SA
      • 10.6.3.1. Participant's Overview
      • 10.6.3.2. Financial Performance
      • 10.6.3.3. Product Benchmarking
      • 10.6.3.4. Recent Developments
    • 10.6.4. F. Hoffmann-La Roche, Ltd.
      • 10.6.4.1. Participant's Overview
      • 10.6.4.2. Financial Performance
      • 10.6.4.3. Product Benchmarking
      • 10.6.4.4. Recent Developments
    • 10.6.5. QuidelOrtho Corporation
      • 10.6.5.1. Participant's Overview
      • 10.6.5.2. Financial Performance
      • 10.6.5.3. Product Benchmarking
      • 10.6.5.4. Recent Developments
    • 10.6.6. Abbott
      • 10.6.6.1. Participant's Overview
      • 10.6.6.2. Financial Performance
      • 10.6.6.3. Product Benchmarking
      • 10.6.6.4. Recent Developments
    • 10.6.7. Agilent Technologies, Inc.
      • 10.6.7.1. Participant's Overview
      • 10.6.7.2. Financial Performance
      • 10.6.7.3. Product Benchmarking
      • 10.6.7.4. Recent Developments
    • 10.6.8. Siemens Healthineers AG
      • 10.6.8.1. Participant's Overview
      • 10.6.8.2. Financial Performance
      • 10.6.8.3. Product Benchmarking
      • 10.6.8.4. Recent Developments
    • 10.6.9. Bio-Rad Laboratories, Inc.
      • 10.6.9.1. Participant's Overview
      • 10.6.9.2. Financial Performance
      • 10.6.9.3. Product Benchmarking
      • 10.6.9.4. Recent Developments
    • 10.6.10. Danaher
      • 10.6.10.1. Participant's Overview
      • 10.6.10.2. Financial Performance
      • 10.6.10.3. Product Benchmarking
      • 10.6.10.4. Recent Developments
    • 10.6.11. Sysmex Corporation
      • 10.6.11.1. Participant's Overview
      • 10.6.11.2. Financial Performance
      • 10.6.11.3. Product Benchmarking
      • 10.6.11.4. Recent Developments
    • 10.6.12. Charles River Laboratories
      • 10.6.12.1. Participant's Overview
      • 10.6.12.2. Financial Performance
      • 10.6.12.3. Product Benchmarking
      • 10.6.12.4. Recent Developments
    • 10.6.13. Quest Diagnostics Incorporated
      • 10.6.13.1. Participant's Overview
      • 10.6.13.2. Financial Performance
      • 10.6.13.3. Product Benchmarking
      • 10.6.13.4. Recent Developments

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global In Vitro Diagnostics Market, By Region, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 5 Global In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 6 Global In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 7 Global In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 8 Global In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 9 Global In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 10 North America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 11 North America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 12 North America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 13 North America In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 14 North America In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 15 North America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 16 U.S. In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 17 U.S. In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 18 U.S. In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 19 U.S. In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 20 U.S. In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 21 Canada In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 22 Canada In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 23 Canada In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 24 Canada In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 25 Canada In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 26 Mexico In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 27 Mexico In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 28 Mexico In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 29 Mexico In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 30 Mexico In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 31 Europe In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 32 Europe In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 33 Europe In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 34 Europe In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 35 Europe In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 36 Europe In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 37 UK In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 38 UK In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 39 UK In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 40 UK In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 41 UK In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 42 Germany In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 43 Germany In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 44 Germany In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 45 Germany America In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 46 Germany In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 47 France In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 48 France In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 49 France In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 50 France In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 51 France In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 52 Spain In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 53 Spain In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 54 Spain In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 55 Spain In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 56 Spain In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 57 Italy In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 58 Italy In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 58 Italy In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 60 Italy In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 61 Italy In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 62 Russia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 63 Russia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 64 Russia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 65 Russia In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 66 Russia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 67 Asia Pacific In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 68 Asia Pacific In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 69 Asia Pacific In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 70 Asia Pacific In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 71 Asia-Pacific In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 72 Asia-Pacific In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 73 China In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 74 China In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 75 China In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 76 China In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 77 China In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 78 Japan In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 79 Japan In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 80 Japan In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 81 Japan In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 82 Japan In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 83 India In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 84 India In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 85 India In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 86 India In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 86 India In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 88 South Korea In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 89 South Korea In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 90 South Korea In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 91 South Korea In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 92 South Korea In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 93 Singapore In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 94 Singapore In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 95 Singapore In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 96 Singapore In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 97 Singapore In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 98 Australia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 99 Australia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 100 Australia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 101 Australia In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 102 Australia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 103 Latin America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 104 Latin America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 105 Latin America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 106 Latin America In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 107 Latin America In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 108 Latin America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 109 Brazil In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 110 Brazil In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 111 Brazil In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 112 Brazil In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 113 Brazil In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 114 Argentina In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 115 Argentina In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 116 Argentina In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 117 Argentina In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 118 Argentina In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 119 MEA In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 120 MEA In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 121 MEA In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 122 MEA In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 123 MEA In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 124 MEA In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 125 South Africa In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 126 South Africa In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 127 South Africa In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 128 South Africa In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 129 UAE In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 130 UAE In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 131 UAE In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 132 UAE In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 133 UAE In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 134 UAE In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)
  • Table 135 Saudi Arabia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 136 Saudi Arabia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 137 Saudi Arabia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 138 Saudi Arabia In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Table 139 Saudi Arabia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in million)

List of Figures

  • Fig. 1 In Vitro Diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 In vitro diagnostic market snapshot
  • Fig. 10 Parent market outlook, 2024
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 In vitro diagnostic market driver impact
  • Fig. 13 Global elderly population
  • Fig. 14 New cancer cases by year
  • Fig. 15 In vitro diagnostic market restraint impact
  • Fig. 16 Market entry strategy
  • Fig. 17 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 Consumer behavior analysis
  • Fig. 20 Strategy mapping
  • Fig. 21 IVD market: Product outlook and key takeaways
  • Fig. 22 IVD market: Products movement analysis
  • Fig. 23 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands)
  • Fig. 24 Reagents market estimates and forecast, 2018 - 2030 (USD Million), Number of reagents sold in millions
  • Fig. 25 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 IVD market: Technology outlook and key takeaways
  • Fig. 27 IVD Market: Technology movement analysis
  • Fig. 28 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 29 Instruments market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Reagents market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Services market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Hematology market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 33 Instruments market for hematology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Reagents market for hematology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Services market for hematology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 37 Instruments market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Reagents market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Services market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 41 Instruments market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Reagents market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Services market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Coagulation market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 45 Instruments market for coagulation estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Reagents market for coagulation estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Services market for coagulation estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Microbiology market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 49 Instruments market for microbiology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Reagents market for microbiology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Services market for microbiology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Others market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 53 Instruments others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Reagents others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Services market for other technology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 IVD market: Application outlook and key takeaways
  • Fig. 57 IVD market: Application movement analysis
  • Fig. 58 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Drug testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 IVD market: End-use outlook and key takeaways
  • Fig. 67 IVD treatment market: End-use movement analysis
  • Fig. 68 Hospitals market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 69 Laboratory market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 70 Home care market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 71 Other market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 72 IVD market: test location outlook and key takeaways
  • Fig. 73 IVD treatment market: Test location movement analysis
  • Fig. 74 Point-of-care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Homecare market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 IVD Market: Regional outlook and key takeaways
  • Fig. 78 IVD market: Regional movement analysis
  • Fig. 79 North America
  • Fig. 80 North America, SWOT
  • Fig. 81 North America. market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 82 U.S. key country dynamics
  • Fig. 83 U.S. market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 84 Canada key country dynamics
  • Fig. 85 Canada market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 86 Mexico key country dynamics
  • Fig. 87 Mexico market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 88 Europe
  • Fig. 89 Europe, SWOT
  • Fig. 90 Europe market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 91 U.K. key country dynamics
  • Fig. 92 U.K. market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 93 Germany key country dynamics
  • Fig. 94 Germany market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 95 Spain key country dynamics
  • Fig. 96 Spain market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 97 France key country dynamics
  • Fig. 98 France market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 99 Italy key country dynamics
  • Fig. 100 Italy market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 101 Russia key country dynamics
  • Fig. 102 Russia market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 103 Denmark key country dynamics
  • Fig. 104 Denmark market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 105 Sweden key country dynamics
  • Fig. 106 Sweden market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 107 Norway key country dynamics
  • Fig. 108 Norway market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 109 Asia Pacific
  • Fig. 110 Asia Pacific, SWOT
  • Fig. 111 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 112 Japan key country dynamics
  • Fig. 113 Japan market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 114 China key country dynamics
  • Fig. 115 China. market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 116 India key country dynamics
  • Fig. 117 India. market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 118 South Korea key country dynamics
  • Fig. 119 South Korea market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 120 Singapore key country dynamics
  • Fig. 121 Singapore market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 122 Thailand key country dynamics
  • Fig. 123 Thailand market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 124 Australia key country dynamics
  • Fig. 125 Australia market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 126 Latin America
  • Fig. 127 Latin America, SWOT
  • Fig. 128 Latin America market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 129 Brazil key country dynamics
  • Fig. 130 Brazil market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 131 Argentina key country dynamics
  • Fig. 132 Argentina market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 133 Middle East & Africa
  • Fig. 134 Middle East & Africa, SWOT
  • Fig. 135 MEA market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 136 South Africa key country dynamics
  • Fig. 137 South Africa market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 138 United Arab Emirates key country dynamics
  • Fig. 139 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 140 Saudi Arabia key country dynamics
  • Fig. 141 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million) (Number of instruments installed in thousands) (Number of reagents sold in millions)
  • Fig. 142 Ansoff matrix
  • Fig. 143 Competition categorization
  • Fig. 144 Company market share analysis, 2024
  • Fig. 145 Global mass spectrometry company market share analysis, 2024
  • Fig. 146 North America mass spectrometry company market share analysis, 2024
  • Fig. 147 Europe mass spectrometry company market share analysis, 2024
  • Fig. 148 Asia Pacific mass spectrometry company market share analysis, 2024
  • Fig. 149 Global immunoassay company market share analysis, 2024
  • Fig. 150 North America immunoassay company market share analysis, 2024
  • Fig. 151 Europe immunoassay company market share analysis, 2024
  • Fig. 152 Asia Pacific immunoassay company market share analysis, 2024
  • Fig. 153 Global PCR company market share analysis, 2024
  • Fig. 154 North America PCR company market share analysis, 2024
  • Fig. 155 Europe PCR company market share analysis, 2024
  • Fig. 156 Asia Pacific PCR company market share analysis, 2024
  • Fig. 157 Company market position analysis
  • Fig. 158 Company market position analysis
  • Fig. 159 Company market position analysis
  • Fig. 160 Company profiles
  • Fig. 161 Regional network map